F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD) and related disorders.F-FP-(+)-DTBZ images. Regional percentage SUR to that of anterior putamen was calculated. Average SUR images were displayed in 2D and 3D space to illustrate the image patterns. The correlation between age and regional VMAT2 uptake was also examined.F-FP-(+)-DTBZ and obviously highest in striatum, followed by nucleus accumbens, hypothalamus, substantia nigra, and raphe nuclei. Quantification analysis revealed striatal VMAT2 density of anterior putamen>posterior putamen>caudate nucleus. Other subcortical regions were with moderate VMAT2 distribution (6∼51% SUR of anterior putamen), while slightly lower VMAT2 was observed...
Background18F-FP-DTBZ has been proven as a biomarker for quantifying the concentration of presynapti...
6-[F-18]fluoro-L-dopa (FDOPA) is a common presynaptic dopaminergic tracer used in examinations by po...
The tau tangle ligand (18)F-AV-1451 ((18)F-T807) binds to neuromelanin in the midbrain, and may ther...
F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD...
<div><p></p><p><sup>18</sup>F-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine t...
We present development and human application of a method for determining the regional cerebral densi...
Abstract [18F]9-fluoropropyl-(+)-dihydrotetrabenazine (18F-(+)DTBZ) is a recently developed PET trac...
We present development and human application of a method for determining the regional cerebral densi...
a novel radiotracer targeting vesicular monoamine transporter type 2 (VMAT2), has been proven as a u...
Aim: L-3,4-dihydroxy-6-18F-fluorophenylalanine (FDOPA) PET allows quantification of presynaptic dopa...
We present development and human application of a method for determining the regional cerebral densi...
Objective: Using 6-[18F]fluoro-l-dopa (FDOPA) and [18F]fluorodeoxyglucoce (FDG) positron emission to...
Aim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects wi...
Parkinson's disease (PD) is characterized by the loss of dopamine-producing neurons in the nigrostri...
PET and SPECT are nuclear medicine imaging techniques that allow for the study of physiological proc...
Background18F-FP-DTBZ has been proven as a biomarker for quantifying the concentration of presynapti...
6-[F-18]fluoro-L-dopa (FDOPA) is a common presynaptic dopaminergic tracer used in examinations by po...
The tau tangle ligand (18)F-AV-1451 ((18)F-T807) binds to neuromelanin in the midbrain, and may ther...
F-FP-(+)-DTBZ as a reference of molecular landmark for clinical diagnosis in Parkinson's disease (PD...
<div><p></p><p><sup>18</sup>F-FP-(+)-DTBZ is a novel PET radiotracer targeting vesicular monoamine t...
We present development and human application of a method for determining the regional cerebral densi...
Abstract [18F]9-fluoropropyl-(+)-dihydrotetrabenazine (18F-(+)DTBZ) is a recently developed PET trac...
We present development and human application of a method for determining the regional cerebral densi...
a novel radiotracer targeting vesicular monoamine transporter type 2 (VMAT2), has been proven as a u...
Aim: L-3,4-dihydroxy-6-18F-fluorophenylalanine (FDOPA) PET allows quantification of presynaptic dopa...
We present development and human application of a method for determining the regional cerebral densi...
Objective: Using 6-[18F]fluoro-l-dopa (FDOPA) and [18F]fluorodeoxyglucoce (FDG) positron emission to...
Aim: L -3,4-dihydroxy-6–18F-fluorophenylalanine (18F-DOPA PET may be used to distinguish subjects wi...
Parkinson's disease (PD) is characterized by the loss of dopamine-producing neurons in the nigrostri...
PET and SPECT are nuclear medicine imaging techniques that allow for the study of physiological proc...
Background18F-FP-DTBZ has been proven as a biomarker for quantifying the concentration of presynapti...
6-[F-18]fluoro-L-dopa (FDOPA) is a common presynaptic dopaminergic tracer used in examinations by po...
The tau tangle ligand (18)F-AV-1451 ((18)F-T807) binds to neuromelanin in the midbrain, and may ther...